Clinical Trials on Biochemically Recurrent Prostate Cancer

Total 8499 results

Matrix Biomed, Inc.
Prostate Oncology Specialists

Not yet recruiting

MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer

Prostate Cancer Recurrent | Biochemical Recurrent Prostate Cancer

United States
University of Florida

Completed

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

Biochemical Recurrent Prostate Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial (DIVINE)

Recurrent Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | Recurrent Castration-Sensitive Prostate Carcinoma

United States
Azienda Ospedaliero-Universitaria Careggi

Recruiting

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE (PSICHE)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Biochemical Relapse Fo Malignant Neoplasm of Prostate

Italy
National Cancer Institute (NCI)

Active, not recruiting

Radium-223 in Biochemically Recurrent Prostate Cancer

Biochemical Recurrent Prostate Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma

United States
Mayo Clinic

Recruiting

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Biochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate Adenocarcinoma

United States
Heinrich-Heine University, Duesseldorf

Recruiting

Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer ([18F]PSMA-1007)

Biochemical Recurrence of Malignant Neoplasm of Prostate | Prostate Cancer After a Radical Treatment | Biochemical Persistence of Prostate Cancer

Germany
Amgen

Active, not recruiting

Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer

Prostate Cancer | High-risk Biochemical Recurrence | High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer | Non-metastatic Castration-sensitive Prostate Cancer

United States, Australia
Bayer

Completed

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide (ARAMON)

Biochemically Recurrent Prostate Cancer

United States
National Cancer Institute (NCI)

Recruiting

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Prostate Cancer | Biochemically Recurrent

United States
M.D. Anderson Cancer Center

Completed

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Prostate Adenocarcinoma | Localized Prostate Carcinoma

United States
Bayer

Active, not recruiting

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP)

Biochemically Recurrent Prostate Cancer

Hungary, United States, Taiwan, Australia, China, New Zealand, Japan, Germany, Canada, Denmark, Poland, Austria, Brazil, Belgium, Czechia, Italy, Portugal, Netherlands, Spain, United Kingdom, Finland, France, Sweden
Mayo Clinic
Congressionally Directed Medical Research Programs

Recruiting

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Locally Advanced Prostate Carcinoma

United States
Thomas Jefferson University
Prostate Cancer Foundation

Completed

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Biochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
National Cancer Institute (NCI)

Completed

Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8

United States
University of Washington

Active, not recruiting

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Prostate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Castration-Resistant Prostate Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Jonsson Comprehensive Cancer Center

Completed

68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | PSA Level Greater Than Fifty

United States
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate Cancer | Biochemical Recurrence

China
Jonsson Comprehensive Cancer Center

Terminated

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8

United States
National Cancer Institute (NCI)

Terminated

Perifosine in Treating Patients With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
National Cancer Institute (NCI)

Completed

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

Recurrent Prostate Cancer | Stage IV Prostate Cancer

Canada
Memorial Sloan Kettering Cancer Center

No longer available

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Recurrent Prostate Cancer | Prostate Cancer

United States
SonaCare Medical

Unknown

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) (STAR)

Recurrent Prostate Cancer

United States, Canada
David M. Schuster, MD

Completed

FACBC for Recurrent Prostate Cancer

Recurrent Prostate Cancer

United States
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Xian-Janssen Pharmaceutical Ltd.

Not yet recruiting

Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study) (ARES)

Prostate Cancer | Biochemical Recurrence | High Risk

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
OHSU Knight Cancer Institute
The Wayne D. Kuni and Joan E. Kuni Foundation

Completed

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
National Cancer Institute (NCI)

Completed

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer (Diagnosis) | Prostate Cancer Stage

China
Curium US LLC

Completed

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur)

Prostate Cancer | Prostate Adenocarcinoma | Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Ignacio Puche Sanz
Hospital Universitario Reina Sofia de Cordoba

Recruiting

Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy (CRIOAND2021)

Recurrent Prostate Cancer | Prostate Cancer | Cryotherapy

Spain
Washington University School of Medicine
The Society of Nuclear Medicine and Molecular Imaging

Not yet recruiting

Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

Recurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States
Centre for Probe Development and Commercialization
McDougall Scientific Ltd.

Completed

Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Recurrent Prostate Cancer | Prostate Cancer Recurrent

Canada
Sophiris Bio Corp

Completed

An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy

Locally Recurrent Prostate Cancer

United States
Lawson Health Research Institute
Cancer Care Ontario; Centre for Probe Development and Commercialization

Recruiting

PSMA-PET Registry for Recurrent Prostate Cancer (PREP)

Recurrent Prostate Cancer

Canada
University Health Network, Toronto
U.S. Army Medical Research and Development Command; Princess Margaret Hospital...

Completed

MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy

Recurrent Prostate Cancer

Canada
University of Colorado, Denver
Boston Scientific Corporation

Terminated

Salvage Cryotherapy in Recurrent Prostate Cancer (SCORE)

Recurrent Prostate Cancer

United States
Prof. Dr. med. Christian Gratzke
Merck Sharp & Dohme LLC

Recruiting

SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy (Pembro-SRT)

Urologic Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate

Germany
David M Lubaroff
United States Department of Defense

Completed

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (APP21)

Recurrent Prostate Cancer

United States
CHU de Quebec-Universite Laval
TerSera Therapeutics LLC

Not yet recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. (HYP-OP-RT)

Prostatic Neoplasms | Prostate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | Neoplasm Recurrence, Local | Reccurent/Metastatic Solid Tumor Disease | Prostate Cancer (Post Prostatectomy)

Canada
Progenics Pharmaceuticals, Inc.

Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States, Canada
Telix Pharmaceuticals (Innovations) Pty Limited
Grand Pharmaceutical (China) Co., Ltd.

Recruiting

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Prostate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | BCR Prostate Carcinoma

China
University Hospital Virgen de las Nieves
Hospital Universitario Reina Sofia de Cordoba; Hospitales Universitarios Virgen... and other collaborators

Recruiting

SCAP vs HIFU for Recurrent Prostate Cancer After Radiation Therapy (SALVPROST)

Recurrent Prostate Cancer | Cryotherapy | High Intensity Focused Ultrasounds

Spain, France

Clinical Trials on Biochemically Recurrent Prostate Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations